Chloroquine and hydroxychloroquine - safety profile of potential COVID-19 drugs from the rheumatologist's perspective
CONCLUSIONS: Chloroquine and hydroxychloroquine at lower doses, as used in rheumatic diseases, prove to be relatively safe. Data from the literature show that high dosage as recommended in COVID-19 treatment may pose a risk of toxicity and require precise management, but prophylactic, long-term use of lower, safe doses might be a promising solution.PMID:33775077 | DOI:10.26444/aaem/127766
Source: Annals of Agricultural and Environmental Medicine : AAEM - Category: Environmental Health Authors: Dominik Majewski Katarzyna Anna Majewska Monika Naskr ęcka Bogna Grygiel-G órniak Source Type: research
More News: Cardiology | COVID-19 | Environmental Health | Heart | Hydroxychloroquine | Hypertension | Liver | Liver Disease | Opthalmology | Pandemics | Rheumatology | Statistics | Study | Toxicology | Urology & Nephrology